Dublin, Aug. 16, 2024 (GLOBE NEWSWIRE) -- The "Organ and Tissue Transplantation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for Organ and Tissue Transplantation is estimated at US$20.0 Billion in 2023 and is projected to reach US$37.2 Billion by 2030, growing at a CAGR of 9.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. 
The growth in the organ and tissue transplantation market is driven by several factors. Increasing incidences of organ failure and the resultant rise in the number of patients on transplant waiting lists directly impact demand for transplantation services. Innovations in surgical technologies and immunosuppressive medications have improved the success rates of transplant surgeries, encouraging more individuals to opt for these life-saving procedures. Additionally, enhanced public awareness and governmental initiatives promoting organ donation have increased the availability of donor organs.
Furthermore, advancements in tissue engineering that may soon provide viable alternatives to donor organs are expanding the potential of the market. Economic development and expanding healthcare infrastructure globally also play crucial roles in increasing access to transplantation services. Together, these factors ensure sustained growth in the transplantation market, highlighting its critical importance in healthcare.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Tissue Products segment, which is expected to reach US$20.5 Billion by 2030 with a CAGR of a 8.7%. The Preservation Solutions segment is also set to grow at 9.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $5.4 Billion in 2023, and China, forecasted to grow at an impressive 13.0% CAGR to reach $8.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Acelity L.P. Inc., CryoLife, Inc., Dr. Franz Kohler Chemie GmbH, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Key Questions Answered:
- How is the Global Organ and Tissue Transplantation Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 188 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $20 Billion |
| Forecasted Market Value (USD) by 2030 | $37.2 Billion |
| Compound Annual Growth Rate | 9.2% |
| Regions Covered | Global |
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Organ and Tissue Transplantation - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
MARKET TRENDS & DRIVERS
- Advances in Surgical Techniques Propel Growth in Organ and Tissue Transplantation Market
- Increasing Incidence of Chronic Diseases Expands Addressable Market Opportunity
- Technological Innovations in Organ Preservation Generate Demand for Advanced Transplant Solutions
- Growth in Organ Donation Awareness Drives Adoption of Transplantation Procedures
- Rising Focus on Immunosuppressive Therapies Strengthens Business Case for Post-Transplant Care
- Impact of 3D Bioprinting Technologies Expands the Market for Customized Implants
- Advances in Artificial Organ Development Drive Adoption in Transplantation
FOCUS ON SELECT PLAYERS (Total 32 Featured)
- Acelity L.P. Inc.
- CryoLife, Inc.
- Dr. Franz Kohler Chemie GmbH
- Exactech, Inc.
- Organ Recovery Systems
- Organ Transport Systems
- Organogenesis, Inc.
- XVIVO Perfusion AB
For more information about this report visit https://www.researchandmarkets.com/r/u76dfi
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
